Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liberty Biosecurity is a specialized biotechnology company focused on biodefense, health security, and the mitigation of emerging biological threats. The company leverages advanced synthetic biology, DNA sequencing, and bioinformatics to develop countermeasures against infectious diseases and engineered biological agents. Their work spans from environmental surveillance and pathogen detection to the development of novel therapeutics and vaccines. Liberty Biosecurity operates at the intersection of national security and life sciences, providing critical R&D services to government agencies and private sector partners. The company is known for its expertise in high-consequence pathogens and its ability to rapidly prototype biological solutions in response to global health crises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liberty.